共 70 条
Dynamic formation of nanostructured particles from vesicles via invertase hydrolysis for on-demand delivery
被引:14
作者:
Fong, Wye-Khay
[1
,2
]
Sanchez-Ferrer, Antoni
[1
]
Ortelli, Francesco Giovanni
[1
]
Sun, Wenjie
[1
]
Boyd, Ben J.
[2
,3
]
Mezzenga, Raffaele
[1
]
机构:
[1] ETH, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland
[2] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 381 Royal Parade, Parkville, Vic 3052, Australia
[3] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville Campus,381 Royal Parade, Parkville, Vic, Australia
来源:
基金:
澳大利亚研究理事会;
关键词:
LIPIDIC CUBIC PHASE;
LIQUID-CRYSTALLINE SYSTEMS;
DRUG-DELIVERY;
X-RAY;
CONTROLLING RELEASE;
IN-VITRO;
BEHAVIOR;
MESOPHASES;
LIPOSOMES;
POLYMORPHISM;
D O I:
10.1039/c6ra26688f
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
The unique multicompartmental nanostructure of lipid-based mesophases can be triggered, on-demand, in order to control the release of encapsulated drugs. In this study, these nanostructured matrices have been designed to respond to a specific enzyme, invertase, an enzyme which catalyses the hydrolysis of sucrose. The effect of two sugar esters upon the phase behaviour of two different lipids which form cubic phases, phytantriol and monolinolein, was investigated. Factors affecting the hydrolysis of the sucrose headgroup are discussed in terms of the molecular structure of the sugar surfactant and also its ability to incorporate into the lipid bilayer. By hydrolysing the incorporated sugar esters, a dynamic change in mesophase nanostructure from vesicles to a cubic phase was observed. This phase change resulted in the triggered release of an encapsulated model drug, fluorescein. This investigation demonstrates, for the first time, that changes on a molecular level by subtly controlling the hydrophilic and hydrophobic features of an amphiphilic additive at the interface by enzymatic hydrolysis can result in a global change in the system and so paves the way towards the design and development of lipid-based matrices which are responsive to specific enzymes for the controlled delivery of pharmaceutically active molecules or functional foods.
引用
收藏
页码:4368 / 4377
页数:10
相关论文